Has Eduard Kraychik, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,621 in general payments to Eduard Kraychik, MD across 92 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eduard Kraychik, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eduard Kraychik, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eduard Kraychik, MD

Psychiatry · Philadelphia, PANPI 1689611196

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $10,500 of the $13,621 with a category attached, or 77.1%. Avanir Pharmaceuticals, Inc. accounts for 82.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $11,219 and has fallen 93.7% since, to $708 in 2025. Among psychiatry clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,621in general payments, 2019–2025

Across 92 payments — averaging $148.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Avanir Pharmaceuticals, Inc.$11K
Otsuka America Pharmaceutical, Inc.$578
Axsome Therapeutics, Inc.$496
AbbVie$429
Amneal Pharmaceuticals LLC$143
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$142
plus $608 from 7 others

What the payments were for

Consulting fees$6685%
Speaking & faculty fees$10,50077%
Travel & lodging$1801%
Food & beverage$2,27217%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Avanir Pharmaceuticals, Inc.	26	$11,225
Otsuka America Pharmaceutical, Inc.	4	$578
Axsome Therapeutics, Inc.	16	$496
AbbVie(2 entities)	12	$429
Amneal Pharmaceuticals LLC	1	$143
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	5	$142
Novo Nordisk	2	$142
Johnson & Johnson(2 entities)	4	$134
Takeda Pharmaceuticals U.S.A., Inc.	5	$86
Pfizer	5	$80
Acadia Pharmaceuticals Inc	6	$78
Teva Pharmaceuticals USA, Inc.	3	$46
Lundbeck LLC	3	$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,621 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.

See all psychiatry providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$108,402

Medicare patients

579

Services billed

1,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
LatudaLurasidone Hcl	11	$15,353
Temazepam	17	$2,663
Escitalopram Oxalate	153	$1,897
Aripiprazole	42	$1,408
Trazodone Hcl	101	$1,403
Bupropion XlBupropion Hcl	58	$1,357
Mirtazapine	129	$1,186
Venlafaxine Hcl ErVenlafaxine Hcl	89	$1,048
Quetiapine Fumarate	71	$963
Sertraline Hcl	65	$507
Olanzapine	36	$447
Bupropion Hcl SrBupropion Hcl	42	$434
Clonazepam	75	$424
Paroxetine Hcl	14	$376
Fluoxetine Hcl	24	$332

Paid to pharmacies, not to this prescriber.

Other psychiatry in Philadelphia

Daniel WeintraubPhiladelphia$647K
Michael ThasePhiladelphia$396K
Freddy AliPhiladelphia$107K
Richard JaffePhiladelphia$101K
Ramesh EluriPhiladelphia$85K
John LaurielloPhiladelphia$62K
Sidra GhafoorPhiladelphia$56K
Maria OquendoPhiladelphia$50K
David OslinPhiladelphia$30K
Bianca PrevidiPhiladelphia$28K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →